4
Changes in Ownership
Axogen, Inc. Filed Acc 0000805928-26-000098
Director sold 13,353 shares at $48.42 ($646,592)
- Director acquired 13,353 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Wendell Amy McBride · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +13,353 | $14.85 | $198,292 | 121,329 | D |
| 2026-08-11 | Sale : show line 2 in the form 10b5-1 | −13,353 | $48.42 | $646,592 | 107,976 | D |
| Open-market sales · 13,353 sh · avg $48.42 · $646,592 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-11 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to purchase) | −13,353 | 0 | D |
Loading xslF345X06/wk-form4_1786565567.xml…